Andrew Hessel is a micro-biologist and geneticist and entrepreneur. He founded the Pink Army Cooperative, and Humane Genomics, Inc. Between 2012-2017, he was a Distinguished Researcher at Autodesk Life Sciences. Hessel is co-chair of Bioinformatics and Biotechnology at Singularity University, and a fellow at the Institute for Science, Society, and Policy at the University of Ottawa. In 2002, he co-founded Miikana Therapeutics, a clinical-stage drug development company. The company was acquired by Entremed in 2006 for $39M in cash and milestones.He received a M.Sc. in biology from University of Calgary 1993-1995 and was Research Operations Manager at Amgen Institute 1995-2002. He has also been involved in Genome Project-Write since the start in 2016 and is currently Chairman of the Board a
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| |
rdfs:comment
| - Andrew Hessel is a micro-biologist and geneticist and entrepreneur. He founded the Pink Army Cooperative, and Humane Genomics, Inc. Between 2012-2017, he was a Distinguished Researcher at Autodesk Life Sciences. Hessel is co-chair of Bioinformatics and Biotechnology at Singularity University, and a fellow at the Institute for Science, Society, and Policy at the University of Ottawa. In 2002, he co-founded Miikana Therapeutics, a clinical-stage drug development company. The company was acquired by Entremed in 2006 for $39M in cash and milestones.He received a M.Sc. in biology from University of Calgary 1993-1995 and was Research Operations Manager at Amgen Institute 1995-2002. He has also been involved in Genome Project-Write since the start in 2016 and is currently Chairman of the Board a (en)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
has abstract
| - Andrew Hessel is a micro-biologist and geneticist and entrepreneur. He founded the Pink Army Cooperative, and Humane Genomics, Inc. Between 2012-2017, he was a Distinguished Researcher at Autodesk Life Sciences. Hessel is co-chair of Bioinformatics and Biotechnology at Singularity University, and a fellow at the Institute for Science, Society, and Policy at the University of Ottawa. In 2002, he co-founded Miikana Therapeutics, a clinical-stage drug development company. The company was acquired by Entremed in 2006 for $39M in cash and milestones.He received a M.Sc. in biology from University of Calgary 1993-1995 and was Research Operations Manager at Amgen Institute 1995-2002. He has also been involved in Genome Project-Write since the start in 2016 and is currently Chairman of the Board and Co-Executive Director. (en)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is foaf:primaryTopic
of | |